ISSN 0303-5212
 
2023, Vol: 48, Issue: 2
48 / 2Current Issue Online FirstArchiveAims and ScopeAbstracting & IndexingMost Accessed ArticlesMost Downloaded ArticlesMost Cited Articles
Required files to be uploaded

Author certificate
Bank Reciept

Original Research 
RMJ. 2022; 47(3): 532-535


Comparative study of Sitagliptin versus Metformin as an Initial Monotherapy in newly diagnosed Type 2 Diabetic subjects

Azhar Memon, Kashif Rasheed Shaikh, Muhammad Atif Ata, Umair Ali Soomro, Shumaila Shaikh, Shumail Saeed Siddiqui.

Abstract
ABSTRACT

Objective: To study, analyse and compare the pharamacological efficacy of sitagliptin and metfromin in terms of blood glucose and glycated HbA1 in type 2 diaebtic (T2DM) subjects.
Methodology: An observational study was conducted at the Suleman Roshan Medical College from March 2019 to February 2020. A sample of 200 diagnosed cases of type 2 DM, divided into 100 sitaglitin and 100 metformin, was selected according to inclusion criteria. Sample was selected by non-probability convenient sampling. After 12 week’s therapy, the blood samples were taken, centrifuged and sera for biochemcial analysis. Fasting (FBG) and random blood glucose (RBG) and glycated HbA1 (HbA1c) were estimated by standard methods. Data was analyzed on SPSS (ver. 21.0) at 95% CI (P≤0.05).
Results: Age of Sitagliptin group was 50.5±11.5 comapred Metformin group 50.1±15.5 years (P=0.07). FBG in sitagliptin was decreased by 46% vs. 37% in metformin; RBG in sitagliptin was decreased by 90% vs. 69% in metformin and HbA1c decreased by 14.35 in sitagliptin vs. 11.4% in metformin. Nausea, vomiting, diarrhoea and headache was noted in 3%, 3%, 6% and 5% of those taking sitagliptin compared to 19%, 5%, 13% and 11% in metformin treated subjects respectively (P<0.05).
Conclusion: Sitagliptin monotherapy maintained effective glycemic control with fewer complications compared to metformin. Sitagliptin shows fewer chances of nausea, vomiting, diarrhoea and headache.

Key words: Sitagliptin, metformin, glycemic control, type 2 diabetics.


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Azhar Memon
Articles by Kashif Rasheed Shaikh
Articles by Muhammad Atif Ata
Articles by Umair Ali Soomro
Articles by Shumaila Shaikh
Articles by Shumail Saeed Siddiqui
on Google
on Google Scholar

How to Cite this Article
Pubmed Style

Memon A, Shaikh KR, Ata MA, Soomro UA, Shaikh S, Siddiqui SS. Comparative study of Sitagliptin versus Metformin as an Initial Monotherapy in newly diagnosed Type 2 Diabetic subjects. RMJ. 2022; 47(3): 532-535.

Web Style

Memon A, Shaikh KR, Ata MA, Soomro UA, Shaikh S, Siddiqui SS. Comparative study of Sitagliptin versus Metformin as an Initial Monotherapy in newly diagnosed Type 2 Diabetic subjects. https://www.rmj.org.pk/?mno=34109 [Access: August 15, 2023].

AMA (American Medical Association) Style

Memon A, Shaikh KR, Ata MA, Soomro UA, Shaikh S, Siddiqui SS. Comparative study of Sitagliptin versus Metformin as an Initial Monotherapy in newly diagnosed Type 2 Diabetic subjects. RMJ. 2022; 47(3): 532-535.


Vancouver/ICMJE Style

Memon A, Shaikh KR, Ata MA, Soomro UA, Shaikh S, Siddiqui SS. Comparative study of Sitagliptin versus Metformin as an Initial Monotherapy in newly diagnosed Type 2 Diabetic subjects. RMJ. (2022), [cited August 15, 2023]; 47(3): 532-535.


Harvard Style

Memon, A., Shaikh, . K. R., Ata, . M. A., Soomro, . U. A., Shaikh, . S. & Siddiqui, . S. S. (2022) Comparative study of Sitagliptin versus Metformin as an Initial Monotherapy in newly diagnosed Type 2 Diabetic subjects. RMJ, 47 (3), 532-535.


Turabian Style

Memon, Azhar, Kashif Rasheed Shaikh, Muhammad Atif Ata, Umair Ali Soomro, Shumaila Shaikh, and Shumail Saeed Siddiqui. 2022. Comparative study of Sitagliptin versus Metformin as an Initial Monotherapy in newly diagnosed Type 2 Diabetic subjects. Rawal Medical Journal, 47 (3), 532-535.


Chicago Style

Memon, Azhar, Kashif Rasheed Shaikh, Muhammad Atif Ata, Umair Ali Soomro, Shumaila Shaikh, and Shumail Saeed Siddiqui. "Comparative study of Sitagliptin versus Metformin as an Initial Monotherapy in newly diagnosed Type 2 Diabetic subjects." Rawal Medical Journal 47 (2022), 532-535.


MLA (The Modern Language Association) Style

Memon, Azhar, Kashif Rasheed Shaikh, Muhammad Atif Ata, Umair Ali Soomro, Shumaila Shaikh, and Shumail Saeed Siddiqui. "Comparative study of Sitagliptin versus Metformin as an Initial Monotherapy in newly diagnosed Type 2 Diabetic subjects." Rawal Medical Journal 47.3 (2022), 532-535. Print.


APA (American Psychological Association) Style

Memon, A., Shaikh, . K. R., Ata, . M. A., Soomro, . U. A., Shaikh, . S. & Siddiqui, . S. S. (2022) Comparative study of Sitagliptin versus Metformin as an Initial Monotherapy in newly diagnosed Type 2 Diabetic subjects. Rawal Medical Journal, 47 (3), 532-535.


Author LoginReviewer LoginEditorial PoliciesConflict of Interest PolicyPlagiarism PolicyAdvertising Policy

About Rawal Medical Journal

Publication, subscription and Editorial office PMA House G/220-B Liaquat Road, Rawalpindi. Phone: 051-555-9812, Fax: 051-553-7088 Email: drnkhokhar@ya ... Read more.



For best results, please use Internet Explorer or Google Chrome.

Contact Information